Response rates according to VEN schedule duration
| Schedule (per 28-day cycle) . | Total VEN . | ≤7 days VEN . | 8-21 days VEN . | 22-28 days VEN . | P value . | Adjusted P value . |
|---|---|---|---|---|---|---|
| n . | 99 . | 42 . | 31 . | 26 . | ≤7 vs 22-28 days . | |
| CR | 26.3% | 9.5% | 32.3% | 46.2% | .001∗ | .002∗ |
| Composite CR+CRi/p | 48.5% | 47.6% | 41.9% | 57.7% | .420 | .394 |
| Months to best response, median | 4.1 | 4.8 | 4.0 | 2.7 | .025∗ | .039∗ |
| 6-month EFS | 38.4% | 26.2% | 45.2% | 50.0% | .049∗ | .087 |
| No unscheduled acute care week 1-12 | 29.3% | 9.5% | 38.7% | 50.0% | .001∗ | .002∗ |
| Schedule (per 28-day cycle) . | Total VEN . | ≤7 days VEN . | 8-21 days VEN . | 22-28 days VEN . | P value . | Adjusted P value . |
|---|---|---|---|---|---|---|
| n . | 99 . | 42 . | 31 . | 26 . | ≤7 vs 22-28 days . | |
| CR | 26.3% | 9.5% | 32.3% | 46.2% | .001∗ | .002∗ |
| Composite CR+CRi/p | 48.5% | 47.6% | 41.9% | 57.7% | .420 | .394 |
| Months to best response, median | 4.1 | 4.8 | 4.0 | 2.7 | .025∗ | .039∗ |
| 6-month EFS | 38.4% | 26.2% | 45.2% | 50.0% | .049∗ | .087 |
| No unscheduled acute care week 1-12 | 29.3% | 9.5% | 38.7% | 50.0% | .001∗ | .002∗ |
CRi/p, CR with incomplete platelet count recovery.
P < .05; adjusted P value used multivariable regression for differences in key baseline characteristics; P values are obtained from logistic regression analysis, other than for months to best response, in which they are from Kaplan-Meier analysis (unadjusted) and multivariable Cox regression analysis (adjusted).